PAPER Pithadia AS, Kochi A, Soper MT, Beck MW, Liu Y, Lee S, Detoma AS, Ruotolo BT, Lim MH
SEARCH RESULTS
330988 RESULTS
PAPER Moretti L, Cristofori I, Weaver SM, Chau A, Portelli JN, Grafman J
Cognitive decline in older adults with a history of traumatic brain injury.
Lancet Neurol. 2012 Dec;11(12):1103-12. PubMed: 23153408PAPER Killick R, Hughes TR, Morgan BP, Lovestone S
Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH.
Neurosci Lett. 2013 Jan 15;533:96-9. PubMed: 23153828PAPER Morris MS
The role of B vitamins in preventing and treating cognitive impairment and decline.
Adv Nutr. 2012 Nov;3(6):801-12. PubMed: 23153734PAPER Esteras N, Alquézar C, Bermejo-Pareja F, Bialopiotrowicz E, Wojda U, Martín-Requero A
Downregulation of extracellular signal-regulated kinase 1/2 activity by calmodulin KII modulates p21(Cip1) levels and survival of immortalized lymphocytes from Alzheimer's disease patients.
Neurobiol Aging. 2013 Apr;34(4):1090-100. PubMed: 23153928PAPER Hua X, Hibar DP, Ching CR, Boyle CP, Rajagopalan P, Gutman BA, Leow AD, Toga AW, Jack CR, Harvey D, Weiner MW, Thompson PM,
Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials.
Neuroimage. 2013 Feb 15;66:648-61. PubMed: 23153970PAPER Royall DR, Palmer RF
Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline.
Alzheimers Dement. 2012 Nov 13; PubMed: 23154050PAPER Chang RY, Nouwens AS, Dodd PR, Etheridge N
The synaptic proteome in Alzheimer's disease.
Alzheimers Dement. 2012 Nov 13; PubMed: 23154051PAPER Roychaudhuri R, Yang M, Deshpande A, Cole GM, Frautschy S, Lomakin A, Benedek GB, Teplow DB
C-Terminal Turn Stability Determines Assembly Differences between Aβ40 and Aβ42.
J Mol Biol. 2013 Jan 23;425(2):292-308. PubMed: 23154165PAPER Poletti M, Nuti A, Cipriani G, Bonuccelli U
Behavioral and Psychological Symptoms of Dementia: Factor Analysis and Relationship with Cognitive Impairment.
Eur Neurol. 2012 Nov 14;69(2):76-82. PubMed: 23154430PAPER Selvakumar K, Prabha RL, Saranya K, Bavithra S, Krishnamoorthy G, Arunakaran J
Polychlorinated biphenyls impair blood-brain barrier integrity via disruption of tight junction proteins in cerebrum, cerebellum and hippocampus of female Wistar rats: Neuropotential role of quercetin.
Hum Exp Toxicol. 2012 Nov 15; PubMed: 23155198PAPER Park SM, Kim KS
Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease.
Prion. 2012 Nov 15;7(2) PubMed: 23154633PAPER Nakamura K, Zhen Zhou X, Ping Lu K
Cis phosphorylated tau as the earliest detectable pathogenic conformation in Alzheimer disease, offering novel diagnostic and therapeutic strategies.
Prion. 2012 Nov 15;7(2) PubMed: 23154634PAPER Kudo W, Petersen RB, Lee HG
Cellular prion protein and Alzheimer disease: Link to oligomeric amyloid-β and neuronal cell death.
Prion. 2012 Nov 15;7(2) PubMed: 23154635PAPER Avrahami L, Farfara D, Shaham-Kol M, Vassar R, Frenkel D, Eldar-Finkelman H
Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model: IN VIVO AND IN VITRO STUDIES.
J Biol Chem. 2013 Jan 11;288(2):1295-306. PubMed: 23155049Current Filters
No filters selected